9/21/2025

Key Insights Significantly high institutional ownership implies Abbott Laboratories' stock price is sensitive to their...

Source: Yahoo

9/21/2025

AbbVie Inc. (NYSE:ABBV) is included among the 12 Best Dividend Paying Stocks to Buy Now. AbbVie Inc. (NYSE:ABBV) is a pharmaceutical company that was spun off from Abbott Laboratories in 2013 and is worth considering for a long-term portfolio. One of the strongest reasons to invest in the company is its dividend. The company’s recent […]

Source: Yahoo

9/20/2025

Pivot Bio, one of the world's most innovative agtech companies, will take center stage during Climate Week in New York City (Sept. 22–24). CEO Chris Abbott will join global business and sustainability leaders to highlight how agriculture is advancing climate solutions, reducing costs and strengthening the economic resilience of rural communities.

Source: Yahoo

9/19/2025

While there have been no injuries as of yet, the FDA said it is monitoring this “potentially high-risk issue.”

Source: Yahoo

9/19/2025

The Smart Medical Devices Market Size valued at US$ 61.7 billion in 2024, is projected to reach US$ 180.4 billion by 2033, expanding at a CAGR of 12.8% (2025–2033), according to the latest report from DataM Intelligence.

Source: Yahoo

9/19/2025

The board of directors of Abbott (NYSE: ABT) today declared a quarterly common dividend of 59 cents per share.

Source: Yahoo

9/19/2025

It's often said that cash is king, but I would take it one step further.

Source: SeekingAlpha

9/19/2025

Catheter tips came off three damaged devices during surgery but none of the patients suffered serious injuries or died.

Source: Yahoo

9/18/2025

ABT's strong Nutrition, Diabetes Care and EPD growth fuel momentum, but macro and currency headwinds challenge its outlook.

Source: Yahoo

9/18/2025

HOLX's global push shows strength, with surgical growth and rising diagnostics use offsetting near-term challenges.

Source: Yahoo

9/18/2025

According to DataM Intelligence, the global AI in remote patient monitoring market reached US$ 5.45 billion in 2023, with a rise to US$ 5.78 billion in 2024, and is expected to reach US$ 10.35 billion by 2033, growing at a CAGR of 6.7% during the forecast period 2025–2033.

Source: Yahoo

9/17/2025

Abbott Laboratories stock outperforms competitors on strong trading day

Source: MarketWatch

9/17/2025

Some say volatility, rather than debt, is the best way to think about risk as an investor, but Warren Buffett famously...

Source: Yahoo

9/16/2025

Abbott (ABT) concluded the recent trading session at $132.76, signifying a +1.09% move from its prior day's close.

Source: Yahoo

9/16/2025

The average brokerage recommendation (ABR) for Abbott (ABT) is equivalent to a Buy. The overly optimistic recommendations of Wall Street analysts make the effectiveness of this highly sought-after metric questionable. So, is it worth buying the stock?

Source: Yahoo

9/16/2025

Abbott (ABT) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.

Source: Yahoo

9/15/2025

Abbott Laboratories stock underperforms Monday when compared to competitors

Source: MarketWatch

9/15/2025

The United States Drug Abuse Testing Market is projected to grow significantly, reaching US$ 3.71 billion by 2033, up from US$ 2 billion in 2024, reflecting a CAGR of 7.11% from 2025 to 2033. This growth is driven by increasing substance misuse, stringent workplace regulations, technological advancements, government support, and rising public awareness. The sector is essential in tackling drug-related challenges through innovative testing methods such as urine, saliva, hair, and blood analyses,

Source: Yahoo

9/13/2025

It's common for many investors, especially those who are inexperienced, to buy shares in companies with a good story...

Source: Yahoo

9/13/2025

The attraction of these dividend stocks isn't limited to their dividends.

Source: Yahoo